Clearance Summary
TRI-POINT BRAND LIQUIMMUNE IMMUNOASSAY CONTR 1,2 & 3 received FDA 510(k) clearance under submission number K934056, sponsored by Medical Analysis Systems, Inc.. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 1993-10-18.
- Submission: K934056
- Applicant / Sponsor: Medical Analysis Systems, Inc.
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class I
- Regulation citation: 21 CFR 862.1660
- Decision date: 1993-10-18
Classification & Regulation
This clearance is catalogued under FDA product code JJY and 21 CFR 862.1660, within the Clinical Chemistry review panel as a Class I device.